Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination.

Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination.
复制标题

DOI:
10.3390/vaccines9070767
复制
发表时间:
2021-07-09
期刊:
影响因子:
7.8
通讯作者:
Testa MA
Testa MA
中科院分区:
医学3区
文献类型:
--
作者:
Savoia E;Piltch-Loeb R;Goldberg B;Miller-Idriss C;Hughes B;Montrond A;Kayyem J;Testa MA

文献摘要

参考文献

被引文献

相似文献

本研究的目的是在美国人口样本中探索 COVID-19 疫苗犹豫的预测因素,包括社会人口因素、合并症、风险认知和歧视经历。我们采用了横断面在线调查研究设计,于 2020 年 12 月 13 日至 23 日期间实施。该调查仅限于居住在美国的受访者,属于疫苗分发的优先群体。收到了来自所有 50 个州以及波多黎各、美属萨摩亚和关岛的 2650 人的答复(答复率为 84%)。代表性最多的五个州是加利福尼亚州 (13%)、纽约州 (10%)、德克萨斯州 (7%)、佛罗里达州 (6%) 和宾夕法尼亚州 (4%)。大多数受访者年龄在 25-44 岁之间(66%),男性(53%),在医疗保健行业工作(61%)。大多数受访者是白人和非西班牙裔 (66%),其次是黑人和非西班牙裔 (14%) 以及西班牙裔 (8%)。经历过种族歧视是对疫苗犹豫不决的一个预测因素。与未报告种族歧视经历的人相比,报告种族歧视经历的人犹豫不决的可能性增加了 21%(OR = 1.21,95% C.I. 1.01–1.45)。 COVID-19 疫苗接种活动期间的沟通和后勤方面需要对个人过去的种族歧视经历保持敏感,以提高疫苗覆盖率。
The goal of this study is to explore predictors of COVID-19 vaccine hesitancy, including socio-demographic factors, comorbidity, risk perception, and experience of discrimination, in a sample of the U.S. population. We used a cross-sectional online survey study design, implemented between 13–23 December 2020. The survey was limited to respondents residing in the USA, belonging to priority groups for vaccine distribution. Responses were received from 2650 individuals (response rate 84%) from all 50 states and Puerto Rico, American Samoa, and Guam. The five most represented states were California (13%), New York (10%), Texas (7%), Florida (6%), and Pennsylvania (4%). The majority of respondents were in the age category 25–44 years (66%), male (53%), and working in the healthcare sector (61%). Most were White and non-Hispanic (66%), followed by Black and non-Hispanic (14%) and Hispanic (8%) respondents. Experience with racial discrimination was a predictor of vaccine hesitancy. Those reporting racial discrimination had 21% increased odds of being at a higher level of hesitancy compared to those who did not report such experience (OR = 1.21, 95% C.I. 1.01–1.45). Communication and logistical aspects during the COVID-19 vaccination campaign need to be sensitive to individuals’ past-experience of racial discrimination in order to increase vaccine coverage.
DOI: 10.1017/s1742058x11000087
发表时间: 2011
期刊: Du Bois review : social science research on race
影响因子: --
作者:
Sternthal MJ;Slopen N;Williams DR
通讯作者: Williams DR
DOI: 10.1016/j.vaccine.2019.01.033
发表时间: 2019-02-21
期刊: VACCINE
影响因子: 5.5
作者:
Quinn, Sandra Crouse;Jamison, Amelia M.;Freimuth, Vicki S.
通讯作者: Freimuth, Vicki S.
DOI: 10.1016/j.eclinm.2020.100495
发表时间: 2020-09-01
期刊: ECLINICALMEDICINE
影响因子: 15.1
作者:
Malik, Amyn A.;McFadden, SarahAnn M.;Omer, Saad B.
通讯作者: Omer, Saad B.
DOI: 10.1186/1471-2458-12-328
发表时间: 2012-05-03
期刊: BMC PUBLIC HEALTH
影响因子: 4.5
作者:
Savoia, Elena;Testa, Marcia A.;Viswanath, Kasisomayajula
通讯作者: Viswanath, Kasisomayajula
DOI: 10.1186/1471-2458-14-484
发表时间: 2014-05-21
期刊: BMC public health
影响因子: 4.5
作者:
Lin L;Savoia E;Agboola F;Viswanath K
通讯作者: Viswanath K